[Value of preparative thin-layer chromatography in the separation and study of the fatty acid composition of various lipid fractions].
Explore the source record for details and available documents.
Cholesterol↗
Biomedical subjects
C MacLeod
Publications and source records attributed to C MacLeod.
Centers of nutritional excellence: Cornell University, Ithaca, New York.
Explore the source record for details and available documents.
Curriculum↗
A comparative study of clarithromycin modified release and amoxicillin/clavulanic acid in the treatment of acute exacerbation of chronic bronchitis.
This phase III, investigator-blind, randomized, parallel-group study compared the efficacy and tolerability of clarithromycin modified release (MR) with those of amoxicillin/clavulanic acid in 250 adult outpatients with acute exacerbationof chronic bronchitis (AECB). Patients received either clarithromycin MR 500 mg once daily or amoxicillin/clavulanic acid 500 mg/125 mg three times daily for 7 days. Primary endpoints were sponsor-defined clinical response and pathogen outcome at the end of treatment. Secondary endpoints were sponsor-defined clinical response and pathogen outcome at study end, investigator-defined clinical response at end of treatment and end of study, resolution or improvement of signs and symptoms, eradication of baseline pathogens, serologic outcome for atypical pathogens, and occurrence of reinfection and superinfection. Adverse events and compliance were also evaluated. Clinical and bacteriologic outcomes with both treatments for all endpoints were statistically equivalent, as were total adverse events, although the incidences of digestive disturbances (13% vs 4%) and discontinuations due to adverse events (8 vs 2 patients; P < or =.05) were significantly higher with amoxicillin/clavulanic acid. Ninety-five percent of patients receiving clarithromycin MR and 80% receiving amoxicillin/clavulanic acid were 100% compliant with medication (P < or =.05). Clarithromycin MR and amoxicillin/clavulanic acid are both well tolerated and effective as therapy for AECB; however, clarithromycin produced fewer side effects and discontinuations and higher compliance rates.
Amoxicillin-Potassium Clavulanate Combination↗
Caring for children in isolated small hospitals--problems and solutions?
A high priority for most parents is to have ready access to paediatric medical services, particularly when their child becomes ill. A difficult balance is therefore sometimes required between the provision of these services in a small local hospital where the throughput of work (and hence opportunities for education and training) will be limited, and the disadvantages of distance and delay where there is geographical isolation from such services. It is also important that doctors have the opportunity to gain experience in the range of environments in which they may work after completion of their training, whether in primary or secondary care. We report an innovative initiative to sustain a local inpatient paediatric service and to enhance the provision of education and training for doctors through development of a training network and rotation. We also highlight issues arising from this, in particular the implications for adequate availability of support from career grade paediatric staff.
Child↗